{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T07:58:49Z","timestamp":1791100729782,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2006,10,24]],"date-time":"2006-10-24T00:00:00Z","timestamp":1161648000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1038\/sj.bjc.6603427","type":"journal-article","created":{"date-parts":[[2006,10,24]],"date-time":"2006-10-24T18:48:55Z","timestamp":1161715735000},"page":"1404-1409","source":"Crossref","is-referenced-by-count":23,"title":["A positive role for PEA3 in HER2-mediated breast tumour progression"],"prefix":"10.1038","volume":"95","author":[{"given":"E","family":"Myers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A D K","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E W","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N J","family":"O'Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L S","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,10,24]]},"reference":[{"key":"BF6603427_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0378-1119(94)00534-Y","volume":"159","author":"EM Berns","year":"1995","unstructured":"Berns EM, Foekens JA, Van Staveren IL, Van Putten WL, de Koning HY, Portengen H, Klijn JG (1995) Oncogene amplification and prognosis in breast cancer: relationship with systemic treatment. Gene 159: 11\u201318","journal-title":"Gene"},{"key":"BF6603427_CR2","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1200\/JCO.1996.14.10.2702","volume":"14","author":"C Carlomagno","year":"1996","unstructured":"Carlomagno C, Perrone F, Gallo C, De Laurentiis M, Lauria R, Morabito A, Pettinato G, Panico L, D'Antonio A, Bianco AR, De Placido S (1996) C-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastasis. J Clin Oncol 14: 2702\u20132708","journal-title":"J Clin Oncol"},{"key":"BF6603427_CR3","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1136\/jcp.2004.016733","volume":"57","author":"FJ Fleming","year":"2004","unstructured":"Fleming FJ, Myers E, Kelly G, Crotty TB, McDermott EW, O'Higgins NJ, Hill AD, Young LS (2004) Expression of SRC-1, AIB1 and PEA3 in HER2 mediated endocrine resistant breast cancer; a predictive role for SRC-1. J Clin Pathol 57: 1069\u20131074","journal-title":"J Clin Pathol"},{"key":"BF6603427_CR4","doi-asserted-by":"publisher","first-page":"6243","DOI":"10.1128\/MCB.23.17.6243-6254.2003","volume":"23","author":"A Goel","year":"2003","unstructured":"Goel A, Janknecht R (2003) Acetylation-mediated transcriptional activation of the Ets protein ER81 by p300. P\/CAF and HER2\/Neu. Mol Cell Biol 23: 6243\u20136254","journal-title":"Mol Cell Biol"},{"key":"BF6603427_CR5","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1200\/JCO.1999.17.5.1474","volume":"17","author":"JM Harvey","year":"1999","unstructured":"Harvey JM, Clark GM, Osbourne CK, Allred DC (1999) Estrogen receptor status by immunohistochemistry is superior to ligand binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 17: 1474\u20131481","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"BF6603427_CR6","doi-asserted-by":"publisher","first-page":"S222","DOI":"10.1067\/msy.2002.119792","volume":"131","author":"J Kinoshita","year":"2002","unstructured":"Kinoshita J, Kitamura K, Tanaka S, Sugimachi K, Ishida M, Saeki H (2002) Clinical significance of PEA3 in human breast cancer. Surgery 131 (Suppl 1): S222\u2013S225","journal-title":"Surgery"},{"key":"BF6603427_CR7","doi-asserted-by":"publisher","first-page":"6570","DOI":"10.1038\/sj.onc.1206779","volume":"22","author":"S Menard","year":"2003","unstructured":"Menard S, Pupa SM, Campiglio M, Tagiabue E (2003) Biologic and therapeutic role of HER2 in cancer. Oncogene 22: 6570\u20136578","journal-title":"Oncogene"},{"key":"BF6603427_CR8","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1038\/sj.bjc.6602156","volume":"91","author":"E Myers","year":"2004","unstructured":"Myers E, Fleming FJ, Crotty TB, Kelly G, McDermott EW, O'Higgins NJ, Hill AD, Young LS (2004) Inverse relationship between ER \u03b2 and SRC-1 predicts outcome in endocrine resistant breast cancer. Br J Cancer 91: 1687\u20131693","journal-title":"Br J Cancer"},{"key":"BF6603427_CR9","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1158\/1078-0432.CCR-04-1192","volume":"11","author":"E Myers","year":"2005","unstructured":"Myers E, Hill AD, Kelly G, McDermott EW, O'Higgins NJ, Buggy Y, Young LS (2005) Associations and interactions between Ets-1 and Ets-2 and co-regulatory proteins SRC-1, AIB1 and NCoR in breast cancer. Clin Cancer Res 11: 2111\u20132122","journal-title":"Clin Cancer Res"},{"key":"BF6603427_CR10","first-page":"1323","volume":"13","author":"RC O'Hagan","year":"1996","unstructured":"O'Hagan RC, Tozer RC, Symons M, McCormick F, Hassell JA (1996) The activity of the Ets transcription factor PEA3 is regulated by two distinct MAPK cascades. Oncogene 13: 1323\u20131333","journal-title":"Oncogene"},{"key":"BF6603427_CR11","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1056\/NEJMoa052122","volume":"53","author":"EH Romond","year":"2005","unstructured":"Romond EH, Prez EA, Bryant J, Suman VJ, Geyer Jr CE, Davidson NE, Tan Chiu E, Martino S, Paik S, Kaufman PA, Swain SM, Pisonsky TM, Fehrenbacher L, Kutteh LA, Vogel VG, Visscher DW, Yothers G, Jenkins RB, Brown AM, Dakhil SR, Mamounas EP, Lingle WL, Klein PM, Ingle JN, Walmark N (2005) Trastuzumab plus adjuvant chemotherapy for operable Her2 positive breast cancer. N Engl J Med 53: 1673\u20131684","journal-title":"N Engl J Med"},{"key":"BF6603427_CR12","doi-asserted-by":"crossref","first-page":"19848","DOI":"10.1016\/S0021-9258(17)32098-7","volume":"269","author":"GK Scott","year":"1994","unstructured":"Scott GK, Daniel JC, Xiong X, Maki RA, Kabat D, Benz CC (1994) Binding of an ETS-related protein within the DNase I hypersensitive site of the HER2\/neu promoter in human breast cancer cells. J Biol Chem 269: 19848\u201319858","journal-title":"J Biol Chem"},{"key":"BF6603427_CR13","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/S1357-2725(97)00086-1","volume":"29","author":"AD Sharrocks","year":"1997","unstructured":"Sharrocks AD, Brown AL, Ling Y, Yates PA (1997) The ETS-domain transcription factor family. Int J Biochem Cell Biol 29: 1371\u20131387","journal-title":"Int J Biochem Cell Biol"},{"key":"BF6603427_CR14","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/S0960-9822(01)00536-X","volume":"11","author":"TG Shepherd","year":"2001","unstructured":"Shepherd TG, Kockeritz L, Szrajbe MR, Muller WJ, Hassell JA (2001) The pea3 subfamily ets genes are required for HER2\/Neu-mediated mammary oncogenesis. Curr Biol 11: 1739\u20131748","journal-title":"Curr Biol"},{"key":"BF6603427_CR15","doi-asserted-by":"publisher","first-page":"10869","DOI":"10.1073\/pnas.191367098","volume":"98","author":"T Sorlie","year":"2001","unstructured":"Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, Van de Rijn M, Jeffrey SS, Thornsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein Lonning P, Borresen-Dale AL (2001) Gene expression patterns of breast carcinomas distinguish tumour subclasses with clinical implications. Proc Natl Acad Sci USA 98: 10869\u201310874","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF6603427_CR16","doi-asserted-by":"publisher","first-page":"8506","DOI":"10.1038\/sj.onc.1206040","volume":"21","author":"PN Span","year":"2002","unstructured":"Span PN, Manders P, Heuvel JJ, Thomas CM, Bosch RR, Beex LV, Sweep CG (2002) Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancer. Oncogene 21: 8506\u20138509","journal-title":"Oncogene"},{"key":"BF6603427_CR17","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1200\/JCO.2002.20.3.719","volume":"20","author":"CL Vogel","year":"2002","unstructured":"Vogel CL, Cobleigh MA, Tripathy D, Gutheil JC, Harris LN, Fehrenbacher L, Slamon DJ, Murphy M, Novotny WF, Burchmore M, Shak S, Stewart SJ, Press M (2002) Efficacy and safety of trastuzumab as a single agent in first line treatment of HER2 overexpressing metastatic breast cancer. J Clin Oncol 20: 719\u2013726","journal-title":"J Clin Oncol"},{"key":"BF6603427_CR18","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/sj.onc.1200914","volume":"14","author":"C Wasylyk","year":"1997","unstructured":"Wasylyk C, Bradford AP, Gutierrez-Hartman A, Wasylyk B (1997) Conserved mechanisms of Ras regulation of evolutionary related transcription factors Ets-1 and Pointed P2. Oncogene 14: 899\u2013913","journal-title":"Oncogene"},{"key":"BF6603427_CR19","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s10549-006-9162-7","volume":"98","author":"WY Xia","year":"2006","unstructured":"Xia WY, Lien HC, Wang X, Pan Y, Sohin A, Kuo YH, Chang KJ, Zhou X, Wang H, Yu Z, Hotobagyi G, Shi DR, Hung MC (2006) Expression of PEA3 and lack of correlation between PEA3 and HER-2\/neu expression in breast cancer. Breast Cancer Res Treat 98: 295\u2013301","journal-title":"Breast Cancer Res Treat"},{"key":"BF6603427_CR20","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1101\/gad.6.3.481","volume":"6","author":"JH Xin","year":"1992","unstructured":"Xin JH, Cowie A, Lachance P, Hassell JA (1992) Molecular cloning and characterization of PEA3, a new member of the Ets oncogene family that is differentially expressed in mouse embryonic cells. Genes Dev 6: 481\u2013496","journal-title":"Genes Dev"},{"key":"BF6603427_CR21","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/72294","volume":"6","author":"X Xing","year":"2000","unstructured":"Xing X, Wang SC, Xia W (2000) The ets protein PEA3 suppresses HER-2\/neu over expression and inhibits tumorigenesis. Nat Med 6: 189\u2013195","journal-title":"Nat Med"},{"key":"BF6603427_CR22","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1128\/MCB.16.2.538","volume":"16","author":"BS Yang","year":"1996","unstructured":"Yang BS, Hauser CA, Henkel G (1996) Ras mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets-1 and c-Ets-2. Mol Cell Biol 16: 538\u2013547","journal-title":"Mol Cell Biol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6603427.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6603427","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6603427.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:24:14Z","timestamp":1684412654000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6603427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,24]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["BF6603427"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6603427","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10,24]]}}}